Last Updated: Wednesday, May 22, 2024
Medical Specialty Drug Authorization
Outpatient Chemotherapy Avastin
Outpatient Chemotherapy Herceptin
Outpatient Medical Injectable Botulinum Toxin
Outpatient Medical Injectable Entyvio
Outpatient Medical Injectable Evenity
Outpatient Medical Injectable Granulocyte Colony-Stimulating Factors Filgrastim
Outpatient Medical Injectable Granulocyte Colony-Stimulating Factors Pegfilgrastim/Eflapegrastim
Outpatient Medical Injectable Infliximab
Outpatient Medical Injectable Intra-Articular Hyaluronan Injections
Outpatient Medical Injectable Intravitreal Injection
Outpatient Medical Injectable Leqvio
Outpatient Medical Injectable Ocrevus
Outpatient Medical Injectable Prolia
Outpatient Medical Injectable Rituximab and Biosimilars
Outpatient Medical Injectable Synagis
Medical Specialty Drug Authorization
Outpatient Chemotherapy Avastin
Outpatient Chemotherapy Herceptin
Outpatient Medical Injectable Botulinum Toxin
Outpatient Medical Injectable Granulocyte Colony-Stimulating Factors
Outpatient Medical Injectable Infliximab
Outpatient Medical Injectable Intra-Articular Hyaluronan Injections
Outpatient Medical Injectable Intravitreal Injection
Outpatient Medical Injectable Prolia